The data published in NEJM highlight the positive Phase 3 VALIANT results at Week 26, which were consistent across adolescent and adult patients with C3G and primary IC-MPGN, including patients with ...

Versus Systems Inc. ("Versus" or the "Company") today announced a new initiative with LiftMedia LDA., to leverage Versus Systems' proprietary interactive engagement tools within Digital Out-of-Home ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

In a statement, Denmark-based Lundbeck said it had carried out a "comprehensive assessment" of the bids on the table for ...

Vietnam’s healthcare system has made significant strides towards international standards over the past decade, Deputy Minister of Health Tran Van Thuan said at a conference on November 25, marking 10 ...

Patients Choice Laboratories (PCL), a diagnostic laboratory headquartered in Indianapolis, has agreed to pay the United States $9,620,000 to resolve allegations that it violated the False Claims Act ...

Qatar has allegedly pumped more than $20 billion into American colleges and other top institutions as part of the Muslim ...

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will host a virtual key opinion leader (KOL) investor event on Monday, December 8, 2025 at 10:30 AM ET. To register, click here.

LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Crucial Innovations Corp ., a pioneering medical cannabis company, announced the signing of a Management Services Agreement (MSA) with Cannabudgrow (Pty) Ltd ...

Patients who used specific immune-boosting herbs before the onset of dermatomyositis had lower rates of autoantibodies, leading researchers to believe they may trigger dermatomyositis through ...

This valuable work provides new insights into the role of lysine acetylation of alpha-synuclein, the protein involved in Parkinson's Disease. The evidence is mostly solid, but the claims around the ...

Neurodegeneration-relevant Lys acetylation sites in αS. (A) αS sequence with positions 12, 21, 23, 32, 43, 45, 58, 60, 80, 96 and 102 marked. (B) Solution NMR structure of micelle-bound αS (PDB: 1qx8) ...